Drug Trial Radar · NCT07795814
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
90
Planned (sponsor's estimate)
Start
Aug 25, 2026
Primary completion
Dec 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Edgewise Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 31, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 30 years, up to 84 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2 placebo-controlled study to evaluate the safety and tolerability of different doses of EDG-15400 in adults with heart failure with preserved ejection fraction (HFpEF).
Conditions
- Heart Failure With Preserved Ejection Fraction
Interventions
EDG-15400 25 mgDrug
EDG-15400 administered orally, once daily
Placebo to match EDG-15400 25 mg or 50 mgDrug
Placebo administered orally, once daily
EDG-15400 50 mgDrug
EDG-15400 administered orally, once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: From baseline through study completion (up to 20 weeks).
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Local Institution - 1
Birmingham, Alabama · Recruiting
Local Institution - 25
Little Rock, Arkansas · Not yet recruiting
Local Institution - 2
Beverly Hills, California · Not yet recruiting
Local Institution - 3
San Diego, California · Not yet recruiting
Local Institution - 4
Vista, California · Recruiting
Local Institution - 24
Gainesville, Florida · Not yet recruiting
Local Institution - 5
Peoria, Illinois · Recruiting
Local Institution - 26
Fort Wayne, Indiana · Not yet recruiting
Local Institution - 6
Indianapolis, Indiana · Not yet recruiting
Local Institution - 7
Houma, Louisiana · Recruiting
Local Institution - 8
Baltimore, Maryland · Not yet recruiting
Local Institution - 9
Ypsilanti, Michigan · Not yet recruiting
Local Institution - 28
Minneapolis, Minnesota · Not yet recruiting
Local Institution - 10
Jackson, Mississippi · Not yet recruiting
Local Institution - 11
Kansas City, Missouri · Not yet recruiting
Local Institution - 12
St Louis, Missouri · Not yet recruiting
Local Institution - 13
New York, New York · Not yet recruiting
Local Institution - 14
Greensboro, North Carolina · Not yet recruiting
Local Institution - 15
Cincinnati, Ohio · Not yet recruiting
Local Institution - 27
Tulsa, Oklahoma · Not yet recruiting
Local Institution - 16
Mechanicsburg, Pennsylvania · Not yet recruiting
Local Institution - 17
Charleston, South Carolina · Not yet recruiting
Local Institution - 18
Dallas, Texas · Not yet recruiting
Local Institution - 19
Houston, Texas · Not yet recruiting
Local Institution - 20
Houston, Texas · Not yet recruiting
Local Institution - 21
Houston, Texas · Not yet recruiting
Local Institution - 22
Charlottesville, Virginia · Not yet recruiting
Local Institution - 23
Seattle, Washington · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.